DALLAS -- Dual antiplatelet therapy (DAPT) proved non-inferior to IV alteplase in Chinese patients with minor non-disabling stroke, a researcher reported. In the ARAMIS trial of patients with acute ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window DALLAS -- Fewer ...
Please provide your email address to receive an email when new articles are posted on . The efficacy of dual antiplatelet therapy vs. aspirin in patients with stroke was similar when given less than ...
In patients who require a valve-in-valve (ViV) transcatheter procedure for a failed aortic bioprosthesis, the choice of antiplatelet therapy has little bearing on major ischemic and bleeding outcomes ...
Please provide your email address to receive an email when new articles are posted on . For adults who undergo PCI with a drug-eluting stent, recommendations for dual antiplatelet therapy have evolved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results